Cite
LncRNA H19 deficiency protects against the structural damage of glomerular endothelium in diabetic nephropathy via Akt/eNOS pathway.
MLA
Liu, Xu, et al. “LncRNA H19 Deficiency Protects against the Structural Damage of Glomerular Endothelium in Diabetic Nephropathy via Akt/ENOS Pathway.” Archives of Physiology & Biochemistry, July 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1080/13813455.2022.2102655.
APA
Liu, X., Li, M.-H., Zhao, Y.-Y., Xie, Y.-L., Yu, X., Chen, Y.-J., Li, P., Zhang, W.-F., & Zhu, T.-T. (2022). LncRNA H19 deficiency protects against the structural damage of glomerular endothelium in diabetic nephropathy via Akt/eNOS pathway. Archives of Physiology & Biochemistry, 1–10. https://doi.org/10.1080/13813455.2022.2102655
Chicago
Liu, Xu, Ming-Hui Li, Yun-Yun Zhao, Yu-Liang Xie, Xin Yu, Yu-Jing Chen, Peng Li, Wei-Fang Zhang, and Tian-Tian Zhu. 2022. “LncRNA H19 Deficiency Protects against the Structural Damage of Glomerular Endothelium in Diabetic Nephropathy via Akt/ENOS Pathway.” Archives of Physiology & Biochemistry, July, 1–10. doi:10.1080/13813455.2022.2102655.